(-0.23%) 5 200.75 points
(-0.23%) 39 105 points
(-0.29%) 18 134 points
(0.89%) $79.69
(-1.05%) $2.16
(-0.12%) $2 319.60
(1.16%) $27.92
(0.50%) $989.50
(0.17%) $0.932
(0.29%) $10.92
(0.29%) $0.802
(1.08%) $92.73
Live Chart Being Loaded With Signals
SenzaGen AB develops, performs, and sells non-animal tests for assessing a substance's allergenicity. The company offers genomic allergen rapid detection (GARD)skin, an in vitro test to identify potential chemical skin sensitizers; GARDpotency, an in vitro add-on test to GARDskin for potency classification; GARDskin Dose-response, an in vitro test for quantitative skin sensitizing potency assessment of chemicals; and GARDair, an in vitro test for identifying chemical respiratory sensitizers, as well as GARDskin medical device, an in vitro skin sensitization testing for medical devices and solid materials...
Stats | |
---|---|
本日の出来高 | 43 892.00 |
平均出来高 | 23 573.00 |
時価総額 | 228.62M |
EPS | SEK0 ( 2024-05-03 ) |
Last Dividend | SEK0 ( N/A ) |
Next Dividend | SEK0 ( N/A ) |
P/E | -10.44 |
ATR14 | SEK0.0910 (0.96%) |
SenzaGen AB 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
SenzaGen AB 財務諸表
Annual | 2023 |
収益: | SEK49.87M |
総利益: | SEK34.93M (70.05 %) |
EPS: | SEK-0.910 |
FY | 2023 |
収益: | SEK49.87M |
総利益: | SEK34.93M (70.05 %) |
EPS: | SEK-0.910 |
FY | 2022 |
収益: | SEK41.77M |
総利益: | SEK27.34M (65.44 %) |
EPS: | SEK-1.030 |
FY | 2021 |
収益: | SEK15.42M |
総利益: | SEK9.45M (61.30 %) |
EPS: | SEK-1.350 |
Financial Reports:
No articles found.
SenzaGen AB
SenzaGen AB develops, performs, and sells non-animal tests for assessing a substance's allergenicity. The company offers genomic allergen rapid detection (GARD)skin, an in vitro test to identify potential chemical skin sensitizers; GARDpotency, an in vitro add-on test to GARDskin for potency classification; GARDskin Dose-response, an in vitro test for quantitative skin sensitizing potency assessment of chemicals; and GARDair, an in vitro test for identifying chemical respiratory sensitizers, as well as GARDskin medical device, an in vitro skin sensitization testing for medical devices and solid materials. It also provides irritation and corrosion testing services. The company offers services through license partners and distributors. It has a collaboration agreement with the Research Institute for Fragrance Materials to develop tests for photosensitization. The company was incorporated in 2010 and is headquartered in Lund, Sweden.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。